OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Vincent Rajkumar: Free Online Tool Helps Predict Myeloma Risk

Mike Linn: What Beating Cancer 3 Times Taught Me About Life

Could Neoadjuvant Immunotherapy Change the Treatment Pathway for MSS Colon Cancer?

Shubh Goel: Building the Next Generation of Female Leaders in Oncology

Miriam Mutebi: The Power of Community Along the Breast Cancer Journey

Oncology News, Insights, Stories by OncoDaily

Australasia BIGR
BIGR

Top Growing Medical Universities in Australasia: 2026 Edition by BIGR

RICE Study: Can Immune Checkpoint Inhibitors Be Used Again After Progression?
Immune Oncology

RICE Study: Can Immune Checkpoint Inhibitors Be Used Again After Progression?

Donna Summer and Lung cancer
Celebrities and Cancer

Donna Summer and Lung Cancer: The Queen of Disco’s Private Battle, and 9/11 Dust Theory

GLOBOCAN 2024: Looking Beyond the Numbers to Understand Global Cancer Disparities

10 Must-Read Posts In GU Oncology This Week

Naoto Ueno: Advancing Oncology Drug Development in Japan at J-HOPE

BTS at W Korea’s Breast Cancer Gala: Why the Event Sparked Global Backlash

Maximilian Merz: The Future of Ciltacabtagene Autoleucel in Myeloma

Registration Open for ESMO 2026

Bishal Gyawali: Why Downplaying Terms Should Not Be Used to Describe Toxicities in Cancer

Voices
Jeff Molter

Jeff Molter: Helping Patients Navigate Their Careers While Getting Cancer Care

Christine Mittaz: The PMC Wellesley to Raise Funds for Cancer Research and Treatment at Dana-Farber

GCCA Hosts Free Educational Webinar on HER2 and Colorectal Cancer

Arjun Chatterjee: Highlighting the Role of Low Fecal Elastase in ICI-Related Diarrhea

Jorge Martins: Pleased to Join City Cancer Challenge as Global Data and Monitoring Manager

Katelyn Sullivan: Pan-Mass Challenge Riders Pedal to Support Cancer Research and Patients

Bulgarian Cancer Scientific Society Raises Awareness Through "Straight Talk About Cancer" - UICC

FDA Approvals
Subcutaneous Isatuximab Multiple Myeloma

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

OncoDaily 100
100 influential survivors

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC

European Society For Medical Oncology (ESMO)

02 Oct
Advanced NSCLC

ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026

European Society For Medical Oncology (ESMO)

02 Oct
Metastatic Breast Cancer 2026

First Line Treatment of Adults with Ph+ ALL. Intermediate Analysis of the ALLPh2022 Trial - Resonance

24 Jul
Ph+ ALL

NCI Data Jamboree: Enhancing Data Sharing and Utility to Advance Cancer Research

National Cancer Institute

16 Nov
NCI Data Jamboree

ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026

European Society For Medical Oncology (ESMO)

29 Sep
Cancer Patients 2026

Immune-oncology
Primary Resistance to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma

Primary Resistance to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma

Tumor Microenvironment: Why It Matters for Cancer Immunotherapy

RICE Study: Can Immune Checkpoint Inhibitors Be Used Again After Progression?

KEYNOTE-C93: Pembrolizumab May Replace Chemotherapy in dMMR Endometrial Cancer

NK-Cell Immunotherapy: The Next Frontier in Cancer Treatment

ChemRNA: A New Generation of Simplified RNA Vaccines for Cancer Immunotherapy

10 Must-Read Posts in Immuno-Oncology This Week

Gastrointestinal-Oncology
BOT/BAL Agenus

Three BOT/BAL Studies in Colorectal Cancer and Sarcoma at ESMO Congress 2026

Could Neoadjuvant Immunotherapy Change the Treatment Pathway for MSS Colon Cancer?

10 Must-Read Posts In GI Oncology This Week

Anal Cancer Survivors Report Lower Physical, Social and Emotional Functioning

PERISCOPE II: Gastrectomy, Cytoreductive Surgery, and HIPEC Do Not Improve Survival in Gastric Cancer With Limited Peritoneal Metastases

Inside the ROBBIN Phase 3 Strategy: Bringing BOT+BAL Into the Neoadjuvant Setting

TOPAZ-1 Post Hoc Analysis: Durvalumab Plus GemCis in Advanced Biliary Tract Cancer

Breast-Oncology
CDK4/6

The CDK4/6 Inhibitor Story Is Entering Its Next Chapter in Breast Cancer

High-Risk Node-Negative HR+/HER2− Early Breast Cancer May Carry Recurrence Risk Similar to N1 Disease

Avutometinib Triplet Shows Feasibility After CDK4/6 Inhibitor Progression in HR+/HER2− Metastatic Breast Cancer

Investigator-Assessed PFS May Be Comparable to BICR in HR+/HER2− Metastatic Breast Cancer Trials

ASCO Updates Breast Cancer Follow-Up Guidelines With Risk-Based Surveillance Approach

Tucatinib Plus Trastuzumab Deruxtecan Shows Activity but No Clear Added Benefit in HER2+ Advanced Breast Cancer

FDA Approves Gedatolisib - Based Therapy for HR+/HER2− Advanced Breast Cancer Without PIK3CA Mutation

Lung-Oncology
EGFR Exon 20

EGFR Exon 20 and HER2-Deregulated NSCLC: The Rare Lung Cancer Subtypes Moving Into a New Therapeutic Era

EMBER-Lung: A Simple EMR Nudge Nearly Doubled Molecular Testing in Early-Stage NSCLC

Lung Transplant for Lung-Only Stage IV NSCLC: A Bold Idea With Major Caveats

Durvalumab With Radiation Shows Promise in Chemotherapy-Ineligible Locally Advanced NSCLC

Sacituzumab Tirumotecan Plus Pembrolizumab Meets Phase III Endpoint in First-Line PD-L1-Negative Non-Squamous NSCLC

ADC-Related Interstitial Lung Disease: A Class-Relevant Toxicity That Requires Early Recognition

Risvutatug Rezetecan Meets Overall Survival Endpoint in Phase III SCLC Trial in China

Oncology Tech
James Hadfield

James Hadfield: Emerging Technologies Aim to Democratize Ultra-Sensitive MRD Testing

The radiopharmaceutical land grab — and the isotope bottleneck no one's pricing in

The Thirteen-Minute Infusion: What Sarclisa's Wearable Injector Signals for Cancer Care

Kalshi Launches Sportsbook-Style Markets on Drug Trials and FDA Decisions

After TROP2 and HER2, Is B7-H3 the Next Big ADC Target?

KRAS Grows Up: The Breakthroughs and the Reckonings

Chris Boshoff: FDA Approves First Platinum-Free Perioperative Regimen for Muscle-Invasive Bladder Cancer

Hematology
Chronic Myelomonocytic Leukemia CMML

Chronic Myelomonocytic Leukemia (CMML): Beyond the Overlap, Toward the Bigger Picture

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

ENDURANCE Trial: 2 Years of Lenalidomide Maintenance Matches Continuous Therapy in Standard-Risk Multiple Myeloma

Peripheral T-Cell Lymphomas (PTCL): Another Evolving Lymphoma Story

Europe Opens the Door to Epcoritamab-R² in 2L Follicular Lymphoma: A New Standard?

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

What the WHO Global Status Report on Cancer 2026 Means for Hematology

Radiotherapy
GammaTile

GammaTile Redefines Postoperative Radiation for Brain Metastases: Lessons from the Phase III ROADS Trial

Life After Anal Cancer: The Hidden Burden of Chemoradiotherapy

Four-Arc Coplanar VMAT Emerges as a Practical Option for Hippocampal-Sparing Whole-Brain Radiotherapy

Unresectable Stage III NSCLC: Precision Redefines Care

A Looming Collapse: Radiation Oncology’s Access Crisis Is No Longer Theoretical 2026

OLIGOPELVIS 2 Shows Acceptable Toxicity With Salvage Nodal Radiotherapy

Early SBRT Before Chemoimmunotherapy Shows Promise in Borderline Resectable and Locally Advanced Pancreatic Cancer

OncoDaily TV
Antonio Jimenez (2)

Antonio Jimenez Jimenez: A Powerful Reminder of Why NMDP Work Matters

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

lisa-thompson-smith-reimbursemement

The System Behind Access of New Cancer Drugs with Lisa Thompson Smith

Elas Sharon, Med News Week

Navigating the Intersection of Immunotherapy and Autoimmunity Dr. Elad Sharon

Rodrigo Sánchez-Bayona open doors

What Makes a Great Oncologist? Insights from Dr. Rodrigo Sánchez-Bayona

Daraxonrasib for Pancreatic Cancer: What’s Next?

Daraxonrasib for Pancreatic Cancer: What’s Next?

1000 doctors standing asco alan sandler

Why 1000 Doctors Gave This Cancer Drug A Standing Ovation?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

ASCO

OncoDaily Highlights from ASCO 2026 Chicago, USA

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Where You Live Shouldn't Dictate Your Cancer Survival: Dr. Benjamin Anderson

Where You Live Shouldn’t Dictate Your Cancer Survival: Dr. Benjamin Anderson

Investing in Cancer Care: Better Health, Stronger Economies: Herb Riband

Investing in Cancer Care: Better Health, Stronger Economies: Herb Riband

Not To Miss
GC-OS 2026 to Bring the Global Cardio-Oncology Community to Williamsburg

GC-OS 2026 to Bring the Global Cardio-Oncology Community to Williamsburg

3rd Symposium “Artificial Intelligence in Public Health Research”

2026 IBRI Global Forum on Science, Philanthropy, and Investment

15 Posts Not To Miss From Best of ASCO Africa 2026

Top Growing Medical Universities in Africa: 2026 Edition by BIGR

WHO Calls for Urgent Action as New Cancer Cases Are Projected to Nearly Double by 2050

20 Posts Not To Miss From ESMO GI 2026, Part 2

OncoGrants
Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

ACOG Foundation 2026 Request for Grant Proposals

ACOG Foundation 2026 Request for Grant Proposals

Clinical Trial Award — DoD OCRP

Clinical Trial Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Eric Bernicker

Eric Bernicker

Oncologists Location Denver, USA
Dario Trapani

Dario Trapani

Oncologists Location Milan, Italy
Robert E. Reiter

Robert E. Reiter

Oncologists Location Los Angeles, USA
Robin Zon

Robin Zon

Oncologists Location Cincinnati, USA
Shabbir Hussain Ali

Shabbir Hussain Ali

Oncologists Location Northampton, United Kingdom
Wade Swenson

Wade Swenson

Oncologists Location Staples, USA
Elie Dib

Elie G. Dib

Oncologists Location Baltimore, USA
Wang Xishan

Wang Xishan

Oncologists Location Beijing, China

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
Rodrigo Lastra del Prado

Rodrigo Lastra del Prado: Benefits of Empathetic Oncologist Patient Communication

ICRA trial

The ICRA trial: Paclitaxel Plus Tremelimumab Shows Activity After Platinum and PD-(L)1 Therapy in Metastatic Urothelial Cancer

Screening - OncoDaily

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-011-0626-7610

Major oral hemorrhage after tongue cancer surgery: A case report
Case Reports & Case Series

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Reviews

Hematology

10.69690/ODMJ-011-0426-7452

Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Case Reports & Case Series